These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 10564557
1. Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders. Hildebrandt M, Rose M, Mayr C, Schüler C, Reutter W, Salama A, Klapp BF. Scand J Immunol; 1999 Nov; 50(5):536-41. PubMed ID: 10564557 [Abstract] [Full Text] [Related]
2. Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders. Hildebrandt M, Rose M, Mayr C, Arck P, Schüler C, Reutter W, Salama A, Klapp BF. Adv Exp Med Biol; 2000 Nov; 477():197-204. PubMed ID: 10849747 [Abstract] [Full Text] [Related]
3. Eating disorders: a role for dipeptidyl peptidase IV in nutritional control. Hildebrandt M, Rose M, Mönnikes H, Reutter W, Keller W, Klapp BF. Nutrition; 2001 Jun; 17(6):451-4. PubMed ID: 11399402 [Abstract] [Full Text] [Related]
4. DPP IV, immune parameters, and psychometrical variables in patients with eating disorders. Fliege H, Rose M, Klapp BF, Hildebrandt M. Adv Exp Med Biol; 2003 Jun; 524():313-20. PubMed ID: 12675253 [No Abstract] [Full Text] [Related]
5. Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease. Hildebrandt M, Rose M, Rüter J, Salama A, Mönnikes H, Klapp BF. Scand J Gastroenterol; 2001 Oct; 36(10):1067-72. PubMed ID: 11589380 [Abstract] [Full Text] [Related]
6. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations. Ruiz P, Zacharievich N, Shenkin M. Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992 [Abstract] [Full Text] [Related]
7. Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa. van West D, Monteleone P, Di Lieto A, De Meester I, Durinx C, Scharpe S, Lin A, Maj M, Maes M. Eur Arch Psychiatry Clin Neurosci; 2000 May; 250(2):86-92. PubMed ID: 10853924 [Abstract] [Full Text] [Related]
8. Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status. Ruiz P, Hao L, Zucker K, Zacharievich N, Viciana AL, Shenkin M, Miller J. Transpl Immunol; 1997 Jun; 5(2):152-61. PubMed ID: 9269038 [Abstract] [Full Text] [Related]
9. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Korom S, De Meester I, Stadlbauer TH, Chandraker A, Schaub M, Sayegh MH, Belyaev A, Haemers A, Scharpé S, Kupiec-Weglinski JW. Transplantation; 1997 May 27; 63(10):1495-500. PubMed ID: 9175816 [Abstract] [Full Text] [Related]
10. Decreased expression and release of dipeptidyl peptidase IV (CD26) in cultured peripheral blood T lymphocytes of oral cancer patients. Uematsu T, Urade M, Yamaoka M. J Oral Pathol Med; 1998 Mar 27; 27(3):106-10. PubMed ID: 9563801 [Abstract] [Full Text] [Related]
11. Reduced expression of dipeptidyl peptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients. Uematsu T, Urade M, Yamaoka M, Yoshioka W. J Oral Pathol Med; 1996 Oct 27; 25(9):507-12. PubMed ID: 8959560 [Abstract] [Full Text] [Related]
12. Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes. Varga T, Somogyi A, Barna G, Wichmann B, Nagy G, Rácz K, Selmeci L, Firneisz G. Pathol Oncol Res; 2011 Dec 27; 17(4):925-30. PubMed ID: 21785903 [Abstract] [Full Text] [Related]
13. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity. Jacotot E, Callebaut C, Blanco J, Krust B, Neubert K, Barth A, Hovanessian AG. Eur J Biochem; 1996 Jul 15; 239(2):248-58. PubMed ID: 8706727 [Abstract] [Full Text] [Related]
14. Human thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny. Ruiz P, Zacharievich N, Hao L, Viciana AL, Shenkin M. Clin Immunol Immunopathol; 1998 Aug 15; 88(2):156-68. PubMed ID: 9714693 [Abstract] [Full Text] [Related]
15. Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients. Buljevic S, Detel D, Pucar LB, Mihelic R, Madarevic T, Sestan B, Varljen J. Rheumatol Int; 2013 Nov 15; 33(11):2867-74. PubMed ID: 23864142 [Abstract] [Full Text] [Related]
17. Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26. Blanco J, Nguyen C, Callebaut C, Jacotot E, Krust B, Mazaleyrat JP, Wakselman M, Hovanessian AG. Eur J Biochem; 1998 Sep 01; 256(2):369-78. PubMed ID: 9760177 [Abstract] [Full Text] [Related]
18. Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C. Firneisz G, Lakatos PL, Szalay F, Hungarian Viral Hepatitis Study Group. Scand J Gastroenterol; 2001 Aug 01; 36(8):877-80. PubMed ID: 11495085 [Abstract] [Full Text] [Related]
19. CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis. Cordero OJ, Varela-Calviño R, López-González T, Calviño-Sampedro C, Viñuela JE, Mouriño C, Hernández-Rodríguez Í, Rodríguez-López M, Aspe de la Iglesia B, Pego-Reigosa JM. PLoS One; 2015 Aug 01; 10(7):e0131992. PubMed ID: 26177310 [Abstract] [Full Text] [Related]
20. CD26/DPP IV in experimental and clinical organ transplantation. Korom S, de Meester I, Belyaev A, Schmidbauer G, Schwemmle K. Adv Exp Med Biol; 2003 Aug 01; 524():133-43. PubMed ID: 12675233 [Abstract] [Full Text] [Related] Page: [Next] [New Search]